APP Pharma to sell generic breast cancer drug - BusinessWeek
APP Pharma to sell generic breast cancer drugBusinessWeekAPP Pharmaceuticals Inc. will join Mylan Inc. and Teva Pharmaceutical Industries Ltd. in marketing generic versions of AstraZeneca PLC's breast cancer drug ...FDA Approves Mylan's Generic Breast cancer DrugBloggingStocks (blog)Teva Launches Generic Version Of AstraZeneca Breast-cancer DrugWall Street JournalMylan Gets FDA Approval For Generic Version Of Breast cancer Drug Arimidex ...RTT NewsPharma Times�-Globes�-Reutersall 120 news articles��

Blog Content

cancer survivors are often parents of young children - Reuters
Boston Globecancer survivors are often parents of young childrenReutersNEW YORK (Reuters Health) - More than 1.5 million cancer survivors in the United States are parents living with children younger than age 18, according to a ...Experts recommend more exercise for cancer survivorsNewsday (subscription)2.85m children live with cancer survivors, study saysBoston Globe (blog)Get moving: cancer survivors urged to exerciseThe Associated PressBusinessWeek�-Lynchburg News and Advance�-EurekAlert (press release)all 164 news articles��

Blog Content

US Sen. Lautenberg of NJ says he's cancer-free - The Associated Press
Washington PostUS Sen. Lautenberg of NJ says he's cancer-freeThe Associated PressRobert Byrd of West Virginia died Monday, has announced that he is cancer-free. Lautenberg made the announcement Saturday at the Garden State Equality ...cancer In Remission, Lautenberg Now Senate's Oldest MemberAHN | All Headline NewsWith Byrd's Death, NJ's Lautenberg Becomes Senate's Oldest MemberNBC New YorkSen. Frank Lautenberg: Lymphoma is 'gone'NorthJersey.comNewsday (subscription)all 182 news articles��

Blog Content

Biovest Announces Mantle Cell lymphoma as Next Target Indication for ... - MarketWatch (press release)
Biovest Announces Mantle Cell lymphoma as Next Target Indication for ...MarketWatch (press release)At the conference, the Company reviewed positive data from an open label Phase II mantle cell lymphoma clinical trial and reported plans to meet with the ...and more��

Blog Content